Ontology highlight
ABSTRACT: Purpose of review
Artificial Intelligence (AI) integration in oncology is transforming therapeutic decision-making by providing clinical decision support. AI may improve treatment precision, but it raises ethical, legal, and informed consent issues. This review examines these paramount AI implementation issues in cancer care. This systematic review followed the PRISMA 2020 guidelines and was prospectively registered in the PROSPERO (CRD420251046482) database. A comprehensive literature search was conducted in PubMed, Embase, and the Cochrane CENTRAL Library to identify studies published between January 2015 and May 2025. AI-supported oncology therapeutic decision-making studies with ethical, legal, or informed consent implications were eligible.Recent findings
Fifteen studi
SUBMITTER: Froicu EM
PROVIDER: S-EPMC12423120 | biostudies-literature | 2025 Aug
REPOSITORIES: biostudies-literature